Page 5 - Cancer Treatment

India' health sector got $1.5-billion investment so far this year

Investment activity in the health care space has not slowed down due to the Covid-19 pandemic

Alembic Pharma gets USFDA nod for generic cancer treatment medication

Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Cyclophosphamide capsules, used in the treatment of different kinds of cancers, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Hikma Pharmaceuticals USA Inc product, Alembic Pharmaceuticals said in a statement. Cyclophosphamide capsules is an alkylating drug indicated for the treatment of malignant disease and minimal change nephrotic syndrome in pediatric patients. According to IQVIA, cyclophosphamide capsules, 25 mg and 50 mg, have an estimated market size of USD 8 million in the US for twelve months ending Sep 2022. Shares of the drug firm were trading 1.32 per cent down at Rs 630.35 apiece on the BSE.

A panoramic history of the cell

Pulitzer Prize winner Siddhartha Mukherjee's The Song of The Cell is a beautifully crafted exposition of the author's own lifelong fascination with the subject

India's cancer treatment infra in rapid expansion mode as cases soar

Capacity build-up via hub-and-spoke route; experts say country would need 10,000-15,000 more day-care beds and 25,000 surgical beds if all reported patients are to avail treatment

Rakuten Medical trying to commercialise novel cancer therapy in India

India accounts for around 26 percent of all head and neck cancer cases globally

Breast cancer among men slowly on the rise & usually detected late: Doctors

The disease is now being diagnosed in relatively younger men

Lupin gets USFDA approval to market generic cancer treatment drug

Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America. The company in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, it said in a statement. The Mumbai-based drug maker's product is a generic version of Bristol-Myers Squibb Company's Sprycel tablets. As per IQVIA MAT data, Dasatinib tablets had an estimated annual sale of USD 1,569 million in the US. Shares of Lupin settled at Rs 662.50 apiece, up 1.49 per cent on the BSE.

Deformation mechanics may be key in cancer treatment: Researchers

A team has uncovered surprising mechanical behaviors of the nucleus. For years, the nucleus within a cell was thought to be elastic like a rubber ball, deforming and snapping back into shape as the cell navigated through pores and between fibers inside the human body. Researchers have now discovered that the nucleus is more complex than originally believed, behaving more like a liquid drop than a rubber ball."The discovery that the nucleus deforms like a liquid drop calls for a fresh look at how the nuclear shape becomes abnormal in diseases like cancer," said Dr. Tanmay Lele, Unocal Professor in the Department of Biomedical Engineering.Lele, a Cancer Prevention & Research Institute of Texas (CPRIT) Scholar, is co-leading the team that uncovered the surprising mechanical behaviors of the nucleus. Their findings were published in Advanced Science in June 2022.The genetic material governing a cell's function and behavior, called the genome, is safely stored in the nucleus. Nearly .

New radiolabelling method for personalised cancer treatment revealed

TU Delft researchers have developed a new method for producing nanocarriers loaded with radioactive salts for imaging and treatment. Because the assembly of these nanocarriers is so simple, the innovation is ideal for clinical research and cancer treatment.The findings of the research were published in the journal 'Advanced Therapeutics'.Chemotherapy is a treatment meant to attack metastasised tumours, but this method unfortunately has many adverse side effects. Nano carriers made out of so-called polymer micelles are a promising, less toxic alternative to chemotherapeutic drugs. Micelles are tiny spheres that can carry around substances inside their core."Clinicians are finding more and more applications of polymer micelles already, mostly to carry chemotherapeutic drugs," co-author of the article and Associate Professor in Applied Radiation & Isotopes Antonia Denkova explained. "Their biggest advantage is that the toxicity to healthy tissue is reduced, meaning that you could ..

Cell-therapy treatment for cancer in India may come at 10% of US cost

Pharma firms and start-ups working to launch it within 2 yrs

Parl panel to discuss affordability of cancer treatment with Health Secy

The Parliamentary Committee on Health and Family Welfare will meet on Monday evening to discuss 'Affordability of Cancer Treatment' with Union Health Secretary Rajesh Bhushan

Researchers find new way of treating devastating brain tumours in adults

The HTL-001 peptide used in the study has undergone safety testing and is suitable for patient trials. These trials are now being considered in GBM and other cancers

First Lady Jill Biden to meet Ukrainian children at St Jude

Her visit to St Jude is part of her and President Joe Biden's so-called Cancer Moonshot effort, which aims to reduce the cancer death rate by at least 50% over the next 25 years

A new study finds importance of malaria drug in treating neck cancers

A study says, hydroxychloroquine inhibits pathways that drive resistance to chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisplatin in animal models

Doyen of cancer treatment in India Krishnan Nair passes away at 81

One of the tallest figures in the country in cancer treatment, Nair passed away on Thursday

Dr Reddy's inks pact with Citius Pharma to sell rights to anti-cancer agent

The drug firm said it has entered into a definitive agreement with Citius to sell all of its rights to E7777 and certain related assets.

Manipal Hospitals launches Radixact System for precise cancer treatment

The technology minimises damage to healthy tissue by delivering high-precision radiation to tumour region which moves with respiration

India spent Rs 2,386 cr in 2020 on oral cancer treatment: Study

India spent approximately Rs 2,386 crore in 2020 on oral cancer treatment, paid for by insurance schemes, government and private sector, spending out of pocket, donations or combination of both.

AstraZeneca Pharma gets DCGI nod for lung cancer treatment drug

AstraZeneca Pharma India on Wednesday said it has received marketing approval from the Drugs Controller General of India (DCGI)for its product for the treatment of non-small cell lung cancer.

Dr Reddy's Laboratories launches cancer treatment drug Capecitabine in US

The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA)